StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)

Close on Nov 18, 2026Market cap $1.56BP/E –Yield –

Enovis price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Enovis's price to sales ratio was 0.7× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.5× to 4.4×, with a median of 1.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×+0.0
2025Dec 31, 20250.7×−0.5
2024Dec 31, 20241.2×−0.6
2023Dec 29, 20231.8×−0.0
2022Dec 30, 20221.9×−2.0
2021Dec 31, 20213.8×+2.4
2020Dec 31, 20201.4×+0.0
2019Dec 31, 20191.4×+0.4
2018Dec 31, 20181.0×−0.5
2017Dec 29, 20171.5×+0.2
2016Dec 30, 20161.3×+0.6
2015Dec 31, 20150.7×−0.7
2014Dec 31, 20141.4×−0.2
2013Dec 31, 20131.6×+0.4
2012Dec 31, 20121.2×−0.6
2011Dec 30, 20111.8×–

More Enovis figures

See a number that looks wrong?